VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 2100 · 117th Congress

Personal Care Products Safety Act

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

3 cosponsors · 2 D, 1 R

1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill requires cosmetics brands and manufacturers to register with the Food and Drug Administration (FDA), provides the FDA with various regulatory authorities, and addresses related issues.

What it does: CRS summary · Introduced in Senate · Jun 17, 2021

Personal Care Products Safety Act

This bill requires cosmetics brands and manufacturers to register with the Food and Drug Administration (FDA), provides the FDA with various regulatory authorities, and addresses related issues.

Cosmetics brand owners and contract manufacturers must annually register their manufacturing facilities with the FDA. Certain entities and facilities, such as manufacturers with gross sales below certain thresholds, are exempted. Registrants with gross annual sales above certain thresholds must pay a registration fee.

Each registration must contain certain information, including an ingredient list for all cosmetic products from a registered facility, with different requirements for registrants that qualify as small businesses.

The FDA may suspend a registration for various reasons, including if the registrant's product has a reasonable probability of causing serious adverse health consequences and the problem cannot be isolated to a single product.

The FDA must annually conduct a safety review of at least five cosmetics ingredients or nonfunctional constituents and, if appropriate, issue a final finding on the safety of that ingredient or constituent. The FDA must also implement regulations for good cosmetics manufacturing practices.

The bill also requires cosmetics brand owners and manufacturers to report to the FDA any serious adverse event associated with their products.

The FDA shall have various authorities to regulate cosmetics, including to (1) order a mandatory recall of a product, (2) inspect the records of manufacturers and processors, and (3) require warning labels for certain products.

The FDA must issue a proposed rule to ban using intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Personal Care Products Safety Act

Latest action (Jun 17, 2021): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S4625)

Policy area: Health · Origin: Senate · Introduced: Jun 17, 2021

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.